28 First Eagle Investments Halozyme Therapeutics Trades
The first Halozyme Therapeutics trade was made in Q4 2013.
Since then First Eagle Investments bought shares twelve more times and sold shares on seventeen occasions. The investor completely sold their stake between Q3 2020 and Q4 2020.
Avg closing price
Price range
Sold -484 Thousand shares
Q4 2020
Avg closing price
$35.95
Price range
$25.81
-
$43.62
Sold 68.1% shares (-1.03 Million shares)
Q3 2020
Avg closing price
$27.85
Price range
$25.74
-
$29.63
Sold 4.2% shares (-66 Thousand shares)
Q2 2020
Avg closing price
$22.56
Price range
$16.25
-
$26.81
Sold 3.2% shares (-52.8 Thousand shares)
Q1 2020
Avg closing price
$18.98
Price range
$13.90
-
$21.83
Sold 0.1% shares (-1 Thousand shares)
Q4 2019
Avg closing price
$17.32
Price range
$14.93
-
$19.53
Sold 3.5% shares (-58.8 Thousand shares)
Q3 2019
Avg closing price
$16.47
Price range
$15.20
-
$17.69
Sold 20.3% shares (-432 Thousand shares)
Q2 2019
Avg closing price
$16.14
Price range
$14.75
-
$17.26
Sold 0.1% shares (-2.5 Thousand shares)
Q1 2019
Avg closing price
$16.20
Price range
$13.94
-
$17.58
Sold 1.9% shares (-42.3 Thousand shares)
Q4 2018
Avg closing price
$15.95
Price range
$13.33
-
$18.66
Increased shares by 2.3% (+48.5 Thousand shares)
Q3 2018
Avg closing price
$17.52
Price range
$16.68
-
$18.41
Sold 29.3% shares (-880 Thousand shares)
Q2 2018
Avg closing price
$18.91
Price range
$16.87
-
$20.30
Sold 33.7% shares (-1.53 Million shares)
Q1 2018
Avg closing price
$19.37
Price range
$17.06
-
$21.20
Sold 29.7% shares (-1.91 Million shares)
Q4 2017
Avg closing price
$18.38
Price range
$16.75
-
$20.80
Sold 12.8% shares (-949 Thousand shares)
Q3 2017
Avg closing price
$13.54
Price range
$11.76
-
$17.40
Sold 3.8% shares (-293 Thousand shares)
Q1 2017
Avg closing price
$12.64
Price range
$9.99
-
$14.68
Increased shares by 3.9% (+292 Thousand shares)
Q4 2016
Avg closing price
$10.95
Price range
$8.32
-
$14.23
Increased shares by 4.1% (+295 Thousand shares)
Q3 2016
Avg closing price
$10.22
Price range
$8.55
-
$12.51
Increased shares by 6.6% (+437 Thousand shares)
Q2 2016
Avg closing price
$9.87
Price range
$7.78
-
$12.05
Increased shares by 54.8% (+2.36 Million shares)
Q1 2016
Avg closing price
$9.41
Price range
$7.17
-
$16.64
Increased shares by 6.1% (+247 Thousand shares)
Q4 2015